Delfi Diagnostics: Funding, Investors & Team (Oct 2026)
Delfi Diagnostics identify disease early, when it is generally reparable, utilizing high accuracy harmless blood tests. It utilizes computerized reasoning and genome sequencing to distinguish extraordinary examples of DNA discontinuity in the blood of patients.
Delfi Diagnostics has raised $259M across 2 funding rounds on record, the most recent an undisclosed round of $34.3M announced in Dec 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Delfi Diagnostics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Delfi Diagnostics Funding Rounds
Delfi Diagnostics raised $225M in a Series B announced in Jul 2022.
3.4 years later, an undisclosed round of $34.3M was announced in Dec 2025.
Delfi Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Delfi Diagnostics Funding Compared to Other Biotechnology Startups
Delfi Diagnostics' latest round of $34.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Delfi Diagnostics in Biotechnology and Baltimore
Companies Similar to Delfi Diagnostics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Delfi Diagnostics Funding FAQs
What does Delfi Diagnostics do?
Delfi Diagnostics identify disease early, when it is generally reparable, utilizing high accuracy harmless blood tests. It utilizes computerized reasoning and genome sequencing to distinguish extraordinary examples of DNA discontinuity in the blood of patients.
How much funding has Delfi Diagnostics raised?
Delfi Diagnostics has raised $259M across 2 rounds on record. The most recent is an undisclosed round of $34.3M announced in Dec 2025.
When did Delfi Diagnostics last raise funding?
Delfi Diagnostics' most recent funding round on record is an undisclosed round of $34.3M, announced in Dec 2025.
Who is the CEO of Delfi Diagnostics?
Victor Velculescu is listed as CEO at Delfi Diagnostics.
Where is Delfi Diagnostics headquartered?
Delfi Diagnostics is based in Baltimore, Maryland, United States.
How many employees does Delfi Diagnostics have?
Delfi Diagnostics is in the 101-250 employee band.
How does Delfi Diagnostics' funding compare to other Biotechnology startups?
Delfi Diagnostics' latest round of $34.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Delfi Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Delfi Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.